195615-83-9
195615-83-9
Chemical Structure
Blarcamesine
- CAS No.: 195615-83-9
- Formula:C19H23NO
- Molecular Weight:281.39
IUPAC Name: 1-(2,2-diphenyltetrahydrofuran-3-yl)-N,N-dimethylmethanamine
InChIKey: BOTHKNZTGGXFEQ-UHFFFAOYSA-N
SMILES: CN(C)CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)OCC1
Biological Activity: Blarcamesine is an orally bioavailable Sigma-1 receptor agonist and muscarinic receptor modulator, with anticonvulsant, anti-amnesic, neuroprotective and antidepressant properties. Blarcamesine ameliorates neurologic impairments in a mouse model of Rett syndrome[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Blarcamesine | 99.16% | Blarcamesine is an orally bioavailable Sigma-1 receptor agonist and muscarinic receptor modulator, with anticonvulsant, anti-amnesic, neuroprotective and antidepressant properties. Blarcamesine ameliorates neurologic impairments in a mouse model of Rett syndrome. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Blarcamesine (Standard) | ≥98% | Blarcamesine (Standard) is the analytical standard of Blarcamesine (HY-105296). This product is intended for research and analytical applications. Blarcamesine is an orally bioavailable Sigma-1 receptor agonist and muscarinic receptor modulator, with anticonvulsant, anti-amnesic, neuroprotective and antidepressant properties. Blarcamesine ameliorates neurologic impairments in a mouse model of Rett syndrome. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
